Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S0232: Lenalidomide + Dexamethasone vs Dexamethasone in Untreated Multiple Myeloma
NCT00064038Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Nov 2004
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lenalidomide in multiple myeloma (MM), sponsored by SWOG Cancer Research Network. Started Nov 2004; status: completed.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00064038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00064038.